We are monitoring the impact of COVID-19 on Latin America Nuclear Imaging Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1547
Share on
Share on

Latin America Nuclear Imaging Market Research Report – Segmented By Diagnostic Technologies, Application, Country (Brazil, Mexico, Argentina, Chile and Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1547
Pages: 132

Latin America Nuclear Imaging Market Size (2021 to 2026)

The nuclear imaging market size in Latin America was worth USD 1.26 billion in 2021 and is estimated to be growing at a CAGR of 7.99% during the forecast period and worth USD 1.86 billion by 2026.

The growth of the Latin American nuclear imaging market is primarily driven by technological improvements in the nuclear imaging area, such as the integration of two or more standalone diagnostic imaging modalities, which increases the procedure's usage. In addition, the rise in the number of cases of illness and diseases such as cardiovascular disease, cancer, and neurological condition around the region is driving demand for nuclear imaging therapies, which is propelling market expansion. 

One of the key causes driving the economy is the exact, precise, and high-quality images digitally generated when radiations are administered to the patient. These images provide organ-specific diagnoses, which leads to illness treatment for the growth of the market.

Nuclear imaging scans are cost-effective, which boosts the market's growth. In addition, the market is growing due to rising awareness of the benefits of nuclear imaging among clinical researchers and clinicians and an increase in the number of applications such as oncology and neurology. Furthermore, the nuclear imaging market is being propelled by the rise in the worldwide geriatric population and the discovery and development of new radiotracers.

However, the lack of availability of radionuclide, the most extensively used isotope for nuclear medicine imaging scans, is expected to impede the growth rate of the Latin American nuclear imaging market. Several healthcare providers have aligned themselves with group-buying organizations (GPOs), integrated health networks (IHNs), and integrated delivery networks (IDNs) in response to increased government pressure to reduce healthcare costs (IDNs). These groups pool their members' purchasing power and negotiate with medical equipment suppliers and manufacturers to lower prices. For example, for mass purchasing of nuclear imaging devices, GPOs, IHNs, and IDNs engage in extensive negotiations. As of 2019, hospital budgets have been drastically decreased due to increased prescription drug costs and a sharp reduction in anticipated budget allocations for Health and Human Services in the United States. According to a study conducted by the American Hospital Association, government funding cuts to hospitals will total USD 218 billion by 2028, causing institutions to designate reduced annual budgets.

This research report on the Latin American nuclear imaging market has been segmented & sub-segmented into the following categories:

By Product: 

  • Standalone PET Nuclear Imaging
  • Standalone SPECT Nuclear Imaging
  • Hybrid Nuclear Imaging

By Application: 

  • Oncology
  • Cardiology
  • Neurology
  • Others

By End-User: 

  • Hospitals
  • Diagnostic Centers
  • Research Centers

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Geographically, the Latin American nuclear imaging market is expanding at a moderate growth rate during the forecast period. The factors such as the favorable payment regulations, the presence of significant enterprises, and sponsored government programs that provide simple access to contemporary infrastructure and imaging for medical purposes have all encouraged its rise.

Brazil accounted for a significant share in the Latin American nuclear imaging market in 2020, and it is expected to witness a predominant share during the forecast period. Increasing investments and funding by the government, technological advancements in the healthcare sector, and raising awareness of the benefits of nuclear imaging among clinical researchers and clinicians are propelling the market growth. The massive rise in spending in the healthcare division has increased the demand for Nuclear Imaging devices. Brazil spends nearly 45% of its total expenditure on healthcare, whereas Argentina spends about 20%. Brazil is one of the largest markets in this region, followed by Mexico, Chile, and Columbia, intensifying their investments in the Nuclear Imaging market.

KEY MARKET PLAYERS:

Companies playing a significant role in the Latin America Nuclear Imaging market in this report are Mallinckrodt plc, Siemens Medical Solutions, Hitachi Medical Corporation, Medtronic Inc., General Electric Co. (healthcare division), IBA Group, Positron Corporation, Philips Medical Systems, Naviscan, Toshiba Medical Systems Corporation, Carestream Health, Lantheus Medical Imaging Inc., Cardinal Health Inc., and Bayer AG.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Diagnostic Technologies                        

                                5.1.1 Introduction           

                                5.1.2 PET Radioisotopes

                                                5.1.2.1 Rubidium-82

                                                5.1.2.2 Fluorine-18

                                                5.1.2.3 Others

                                5.1.3 SPECT Radioisotopes          

                                                5.1.3.1 Thallium-201

                                                5.1.3.2 Technetium-99m

                                                5.1.3.3 Xenon-133

                                                5.1.3.4 Iodine-123

                                                5.1.3.5 Others

                                5.1.4 Y-o-Y Growth Analysis, By Diagnostic Technologies                

                                5.1.5 Market Attractiveness Analysis, By Diagnostic Technologies              

                                5.1.6 Market Share Analysis, By Diagnostic Technologies               

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 PET             

                                                5.2.2.1 Cardiology

                                                5.2.2.2 Oncology

                                                5.2.2.3 Neurology

                                                5.2.2.4 Others

                                5.2.3 SPECT        

                                                5.2.3.1 Lymphoma

                                                5.2.3.2 Neurology

                                                5.2.3.3 Cardiology

                                                5.2.3.4 Thyroid

                                                5.2.3.5 Others

                                5.2.4 Y-o-Y Growth Analysis, By Application         

                                5.2.5 Market Attractiveness Analysis, By Application        

                                5.2.6 Market Share Analysis, By Application         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Diagnostic Technologies

                                                6.1.3.3 By Application

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Diagnostic Technologies

                                                6.1.4.3 By Application

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Diagnostic Technologies

                                                6.1.5.3 By Application

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Mallinckrodt plc                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Siemens Medical Solutions                  

                8.3 Hitachi Medical Corporation               

                8.4 Medtronic Inc.                          

                8.5 General Electric Co. (healthcare division)                       

                8.6 IBA Group                   

                8.7 Positron Corporation                              

                8.8 Philips Medical Systems                        

                8.9 Naviscan                      

                8.10 Toshiba Medical Systems Corporation                          

                8.11 Carestream Health                

                8.12 Lantheus Medical Imaging Inc.                         

                8.13 Cardinal Health Inc.                              

                8.14 Bayer AG                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Nuclear Imaging Market, By Region, From 2021 to 2026 (USD Billion)
  2. Latin America Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  3. Latin America PET Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  4. Latin America Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  5. Latin America Rubidium-82 Market, By Region, From 2021 to 2026 (USD Billion)
  6. Latin America Fluorine-18 Market, By Region, From 2021 to 2026 (USD Billion)
  7. Latin America Other PET radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  8. Latin America SPECT Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  9. Latin America Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  10. Latin America Thallium-201 Market, By Region, From 2021 to 2026 (USD Billion)
  11. Latin America Technetium-99m Market, By Region, From 2021 to 2026 (USD Billion)
  12. Latin America Xenon-133 Market, By Region, From 2021 to 2026 (USD Billion)
  13. Latin America Iodine-123 Market, By Region, From 2021 to 2026 (USD Billion)
  14. Latin America Other SPECT radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  15. Latin America Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  16. Latin America PET Market, By Region, From 2021 to 2026 (USD Billion)
  17. Latin America Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  18. Latin America Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  19. Latin America Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  20. Latin America Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  21. Latin America Other PET applications Market, By Region, From 2021 to 2026 (USD Billion)
  22. Latin America SPECT Market, By Region, From 2021 to 2026 (USD Billion)
  23. Latin America Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  24. Latin America Lymphoma Market, By Region, From 2021 to 2026 (USD Billion)
  25. Latin America Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  26. Latin America Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  27. Latin America Thyroid Market, By Region, From 2021 to 2026 (USD Billion)
  28. Latin America Other SPECT applications Market, By Region, From 2021 to 2026 (USD Billion)
  29. Brazil Nuclear Imaging Market, By Diagnostic Technologies, From 2021 to 2026 (USD Billion)
  30. Brazil Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  31. Brazil Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  32. Brazil Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  33. Brazil Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  34. Brazil Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  35. Argentina Nuclear Imaging Market, By Diagnostic Technologies, From 2021 to 2026 (USD Billion)
  36. Argentina Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  37. Argentina Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  38. Argentina Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  39. Argentina Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  40. Argentina Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  41. Mexico Nuclear Imaging Market, By Diagnostic Technologies, From 2021 to 2026 (USD Billion)
  42. Mexico Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  43. Mexico Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  44. Mexico Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  45. Mexico Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  46. Mexico Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample